Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Conditions: Liposarcoma; CRC; Prostate Cancer; Breast Neoplasms; Adenocarcinoma of Lung; Solid Tumors Interventions: Drug: PF-07220060; Combination Product: Letrozole; Combination Product: Fulvestrant Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials